Inhibition of metastases by a serum factor associated to concomitant resistance induced by unrelated murine tumors.
- P Di Gianni
- M Franco
- R P Meiss
- S Vanzulli
- I Piazzon
- C D Pasqualini
- O D Bustuoabad
- R A Ruggiero
Affiliations: Division Medicina Experimental, Instituto de Investigaciones Hematologicas and Centro de Estudios Oncologicos, Academia Nacional de Medicina, 1425 Buenos Aires, Argentina.
- Published online on: September 1, 1999 https://doi.org/10.3892/or.6.5.1073
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Murine lung metatases growing undisturbed by the primary tumor were significantly inhibited by the concomitant resistance induced by a secondary subcutaneous implant of two unrelated tumors. Such inhibition was T-independent since it was also observed in nude mice; its full expression was dependent on the presence of the secondary tumor implant and it was exerted on both macroscopic and microscopic established metastases and not on the process of tumor cell dissemination from the primary tumor. Direct and indirect mechanisms seemed to be involved, the former affecting the metastatic cells per se by causing a decrease in proliferation and an increase in apoptosis while the latter affected neo-vascularization. These antitumor and antiangiogenic effects could be attributed to a serum factor induced by the unrelated tumors generating concomitant resistance. This factor proved to be heat, acid and alkaline resistant and dialysable; it was recovered in an HPLC column with maximum absorption at 215 and 266 nm; it was anionic at neutral pH, exhibiting free carboxil groups and one or more molecules of tyrosine, with a molecular weight between 870 and 1300 Dalton. Intravenous administration of this factor significantly inhibited lung metastases, decreasing mitosis and increasing apoptosis similar to that observed in the presence of the unrelated tumors.